User profiles for ALFRED MAHR

Alfred Mahr

Kusnacht Practice - Zurich-Zollikon
Verified email at kusnachtpractice.ch
Cited by 33503

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological …

…, B Hellmich, W Koldingsnes, A Mahr… - Annals of the …, 2007 - ard.bmj.com
Background: The classification of antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
and polyarteritis nodosa (PAN) for epidemiology studies is confusing. The existing …

[HTML][HTML] Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis

…, E Daugas, T Papo, B Bonnotte, A Mahr… - … England Journal of …, 2014 - Mass Medical Soc
Background The combination of cyclophosphamide and glucocorticoids leads to remission
in most patients with antineutrophil cytoplasm antibody (ANCA)–associated vasculitides. …

Long-term patient survival in ANCA-associated vasculitis

…, P Höglund, D Jayne, R Luqmani, A Mahr… - Annals of the …, 2011 - ard.bmj.com
Background Wegener's granulomatosis and microscopic polyangiitis are antineutrophil
cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and mortality. …

Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg‐Strauss syndrome in a French urban multiethnic population in …

A Mahr, L Guillevin, M Poissonnet… - Arthritis Care & …, 2004 - Wiley Online Library
Objective To estimate the prevalences of polyarteritis nodosa (PAN), microscopic polyangiitis
(MPA), Wegener's granulomatosis (WG), and Churg‐Strauss syndrome (CSS). Methods …

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

…, C Dejaco, G Hatemi, N Hollinger, A Mahr… - Annals of the …, 2020 - ard.bmj.com
Background Since the publication of the European League Against Rheumatism (EULAR)
recommendations for the management of large vessel vasculitis (LVV) in 2009, several …

The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort

L Guillevin, C Pagnoux, R Seror, A Mahr, L Mouthon… - Medicine, 2011 - journals.lww.com
The 1996 Five-Factor Score (FFS) for systemic necrotizing vasculitides (polyarteritis nodosa
[PAN], microscopic polyangiitis [MPA], and Churg-Strauss syndrome [CSS]) is used to …

Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis …

…, B Godeau, R Seror, B Dunogué, A Mahr… - Arthritis & …, 2013 - Wiley Online Library
Objective Earlier studies of eosinophilic granulomatosis with polyangiitis (Churg‐Strauss) (EGPA),
with limited patient numbers and followup durations, demonstrated that clinical …

Antineutrophil cytoplasmic antibodies and the Churg–Strauss syndrome

R Sablé-Fourtassou, P Cohen, A Mahr… - Annals of internal …, 2005 - acpjournals.org
Background: Since testing for antineutrophil cytoplasmic antibodies (ANCA) became
available for routine evaluation, no large homogeneous cohort of patients with the Churg–Strauss …

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta‐analysis

AD Mahr, JA Jover, RF Spiera… - Arthritis & …, 2007 - Wiley Online Library
Objective To reevaluate the efficacy and safety of adjunctive low‐dose methotrexate (MTX)
in giant cell arteritis (GCA). Methods An individual patient data meta‐analysis of 3 …

[HTML][HTML] Azathioprine or methotrexate maintenance for ANCA-associated vasculitis

C Pagnoux, A Mahr, MA Hamidou… - … England Journal of …, 2008 - Mass Medical Soc
Background Current standard therapy for Wegener's granulomatosis and microscopic
polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed by a …